DK1398379T3 - Forbindelser og fremgangsmåder til immunterapi og diagnose af tuberkulose - Google Patents

Forbindelser og fremgangsmåder til immunterapi og diagnose af tuberkulose

Info

Publication number
DK1398379T3
DK1398379T3 DK03021501T DK03021501T DK1398379T3 DK 1398379 T3 DK1398379 T3 DK 1398379T3 DK 03021501 T DK03021501 T DK 03021501T DK 03021501 T DK03021501 T DK 03021501T DK 1398379 T3 DK1398379 T3 DK 1398379T3
Authority
DK
Denmark
Prior art keywords
tuberculosis
compounds
diagnosis
methods
immunotherapy
Prior art date
Application number
DK03021501T
Other languages
Danish (da)
English (en)
Inventor
Yasir A W Skeiky
Thomas S Vedvick
Steven G Reed
Antonio Campos-Neto
Daniel R Twardzik
Davin C Dillon
Raymond L Houghton
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27541835&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1398379(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Corixa Corp filed Critical Corixa Corp
Application granted granted Critical
Publication of DK1398379T3 publication Critical patent/DK1398379T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK03021501T 1995-09-01 1996-08-30 Forbindelser og fremgangsmåder til immunterapi og diagnose af tuberkulose DK1398379T3 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US52343695A 1995-09-01 1995-09-01
US53363495A 1995-09-22 1995-09-22
US62087496A 1996-03-22 1996-03-22
US65968396A 1996-06-05 1996-06-05
US68057496A 1996-07-12 1996-07-12
PCT/US1996/014674 WO1997009428A2 (fr) 1995-09-01 1996-08-30 Composes et methodes d'immunotherapie et de diagnostic de la tuberculose

Publications (1)

Publication Number Publication Date
DK1398379T3 true DK1398379T3 (da) 2007-01-08

Family

ID=27541835

Family Applications (4)

Application Number Title Priority Date Filing Date
DK03021501T DK1398379T3 (da) 1995-09-01 1996-08-30 Forbindelser og fremgangsmåder til immunterapi og diagnose af tuberkulose
DK96933009T DK0851927T3 (da) 1995-09-01 1996-08-30 Forbindelser til immunterapi og diagnosticering af tuberkulose
DK03005931T DK1347055T3 (da) 1995-09-01 1996-08-30 Forbindelser til immunbehandling og diagnose af tuberkulose
DK01126628T DK1203817T3 (da) 1995-09-01 1996-08-30 Forbindelser og fremgangsmåder til immunterapi og diagnose af tuberkulose

Family Applications After (3)

Application Number Title Priority Date Filing Date
DK96933009T DK0851927T3 (da) 1995-09-01 1996-08-30 Forbindelser til immunterapi og diagnosticering af tuberkulose
DK03005931T DK1347055T3 (da) 1995-09-01 1996-08-30 Forbindelser til immunbehandling og diagnose af tuberkulose
DK01126628T DK1203817T3 (da) 1995-09-01 1996-08-30 Forbindelser og fremgangsmåder til immunterapi og diagnose af tuberkulose

Country Status (24)

Country Link
EP (5) EP1398379B1 (fr)
JP (5) JP4382160B2 (fr)
KR (1) KR100433750B1 (fr)
CN (1) CN1117149C (fr)
AT (5) ATE426025T1 (fr)
AU (1) AU727602B2 (fr)
BR (2) BR9612997B1 (fr)
CA (3) CA2684425A1 (fr)
CY (2) CY2570B1 (fr)
CZ (3) CZ300688B6 (fr)
DE (4) DE69636046T2 (fr)
DK (4) DK1398379T3 (fr)
ES (4) ES2271449T3 (fr)
HK (1) HK1059282A1 (fr)
HU (2) HU225979B1 (fr)
IL (1) IL123506A (fr)
MX (1) MX9801638A (fr)
NO (4) NO324372B1 (fr)
NZ (1) NZ319377A (fr)
PL (1) PL186774B1 (fr)
PT (4) PT851927E (fr)
SI (1) SI0851927T1 (fr)
TR (5) TR200806259T2 (fr)
WO (1) WO1997009428A2 (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641814B1 (en) 1997-04-02 2003-11-04 Statens Serum Institut Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
WO1998016645A2 (fr) * 1996-10-11 1998-04-23 Corixa Corporation Composes et procedes pour diagnostiquer la tuberculose
US6627198B2 (en) 1997-03-13 2003-09-30 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis antigens and their uses
US6350456B1 (en) 1997-03-13 2002-02-26 Corixa Corporation Compositions and methods for the prevention and treatment of M. tuberculosis infection
US6544522B1 (en) 1998-12-30 2003-04-08 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
ES2291810T3 (es) * 1997-04-02 2008-03-01 Statens Serum Institut Fragmentos de acido nucleico y fragmentos de polpeptidos derivados de m. tuberculosis.
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
US6613881B1 (en) * 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
US6555653B2 (en) 1997-05-20 2003-04-29 Corixa Corporation Compounds for diagnosis of tuberculosis and methods for their use
WO1999004005A1 (fr) * 1997-07-16 1999-01-28 Institut Pasteur Polynucleotide codant fonctionellement pour la proteine lhp de mycobacterium tuberculosis, fragments derives biologiquement actifs, et procedes utilisant ce polynucleotide
EP1029053A1 (fr) * 1997-11-10 2000-08-23 Statens Seruminstitut Fragments d'acides nucleiques et fragments polypeptidiques derives de mycobacterium tuberculosis
EP1484405A1 (fr) * 1997-11-10 2004-12-08 Statens Serum Institut Fragments d'acide nucléique et fragments polypeptidiques derivés de M. tuberculosis
WO1999051748A2 (fr) * 1998-04-07 1999-10-14 Corixa Corporation Proteines hybrides d'antigenes de mycobacterium tuberculosis et leurs utilisations
GB9808720D0 (en) * 1998-04-23 1998-06-24 Smithkline Beecham Biolog Novel compounds
ID29858A (id) * 1998-11-04 2001-10-18 Isis Innovation Uji diagnostik tuberkulosis
AU2594500A (en) * 1998-12-24 2000-07-31 Corixa Corporation Methods for using mycobacterium tuberculosis molecules as immunological adjuvants
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
DK1214088T3 (da) 1999-05-04 2009-08-24 Univ New Jersey Med Proteiner udtrykt af Mycobacterium tuberculosis og ikke af BCG og anvendelse heraf som diagnostiske reagenser og vacciner
US7009042B1 (en) * 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
AU2001241738A1 (en) 2000-02-25 2001-09-03 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
PT1542732E (pt) 2000-06-20 2009-11-06 Corixa Corp Proteínas de fusão de mycobacterium tuberculosis
US7026465B2 (en) 2002-02-15 2006-04-11 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis
ITRM20040091A1 (it) 2004-02-19 2004-05-19 Istituto Naz Per Le Malattie Test immunologico rapido per la diagnosi ed il monitoraggio dell'infezione tubercolare.
FI119445B (fi) * 2004-10-29 2008-11-14 Waertsilae Finland Oy Polttomoottorin polttoaineen syöttöjärjestelmän paineen värähtelyn vaimennin
BRPI0518933A2 (pt) 2004-11-16 2008-12-16 Crucell Holland B V E Aeras Gl adenovÍrus recombinante defeituoso de replicaÇço, vetor de polinucleotÍdeo recombinante, vacina multivalente da tuberculose, e, uso do antÍgeno tb10.4 de mycobacterium
EP2457926B1 (fr) 2005-04-29 2014-09-24 GlaxoSmithKline Biologicals S.A. Nouveau procédé pour la prévention ou le traitement d'une infection de tuberculose M.
FR2952058B1 (fr) 2009-10-29 2013-10-04 Centre Nat Rech Scient Procede de ligation native de polypeptides
EA201290590A1 (ru) 2010-01-27 2013-03-29 Глаксосмитклайн Байолоджикалс С.А. Модифицированные туберкулезные антигены
CN103260642B (zh) 2010-12-14 2018-03-16 葛兰素史密丝克莱恩生物有限公司 分枝杆菌抗原组合物
FR2971509B1 (fr) * 2011-02-16 2013-02-22 Centre Nat Rech Scient Procede de preparation de peptides par assemblage de multiples fragments peptidiques
CN103290030A (zh) * 2012-02-23 2013-09-11 上海交通大学 一种结核分枝杆菌标志物HtdY的重组蛋白及其制备方法和临床应用
EP3563865A3 (fr) * 2012-05-04 2019-12-04 Pfizer Inc Régimes immunothérapeutiques basés sur des antigènes associés à la prostate et un vaccin
CN111233992A (zh) * 2014-04-04 2020-06-05 韦斯塔隆公司 人工活化的肽
GB201513176D0 (en) 2015-07-27 2015-09-09 Glaxosmithkline Biolog Sa Novel methods for inducing an immune response
FR3048286B1 (fr) * 2016-02-26 2021-01-22 Omunis Peptides immunogenes et leur utilisation
CN107304231B (zh) * 2016-04-18 2021-01-01 华中农业大学 一种结核分枝杆菌融合蛋白及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244539A1 (en) * 1973-07-13 1975-04-18 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
FR2265402A1 (en) * 1974-03-29 1975-10-24 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
US4876089A (en) * 1984-09-06 1989-10-24 Chiron Corporation Feline leukemia virus protein vaccines
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
US5330754A (en) * 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
DK79793D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine

Also Published As

Publication number Publication date
EP0851927B1 (fr) 2003-10-22
ES2210392T3 (es) 2004-07-01
ATE513915T1 (de) 2011-07-15
JP2007228972A (ja) 2007-09-13
CZ62898A3 (cs) 1999-10-13
PT1398379E (pt) 2007-01-31
NO980883D0 (no) 1998-02-27
DE69636487T2 (de) 2007-05-03
PT1203817E (pt) 2006-08-31
TR200901109T1 (tr) 2012-02-21
DK0851927T3 (da) 2004-01-26
CZ297406B6 (cs) 2006-12-13
EP1398379B1 (fr) 2006-08-23
DK1203817T3 (da) 2006-08-14
TR199800411T1 (xx) 1998-05-21
CA2653566A1 (fr) 1997-03-13
ES2262595T3 (es) 2006-12-01
CY2570B1 (en) 2008-07-02
EP1203817B1 (fr) 2006-04-12
ES2271449T3 (es) 2007-04-16
CA2684425A1 (fr) 1997-03-13
HUP9900902A2 (hu) 1999-07-28
EP1347055A2 (fr) 2003-09-24
DE69630457D1 (de) 2003-11-27
EP1712628A2 (fr) 2006-10-18
CA2230885A1 (fr) 1997-03-13
DK1347055T3 (da) 2009-06-29
DE69637879D1 (de) 2009-04-30
NO20070619L (no) 1998-04-27
JP2001517069A (ja) 2001-10-02
HK1059282A1 (en) 2004-06-25
IL123506A0 (en) 1998-10-30
ES2324529T3 (es) 2009-08-10
CN1117149C (zh) 2003-08-06
EP1203817A3 (fr) 2003-01-29
EP1712628B1 (fr) 2011-06-22
NO336288B1 (no) 2015-07-13
TR200403064T2 (tr) 2005-08-22
CA2653566C (fr) 2013-06-25
DE69636487D1 (de) 2006-10-05
WO1997009428A3 (fr) 1997-07-17
PL325373A1 (en) 1998-07-20
ATE252640T1 (de) 2003-11-15
CN1200147A (zh) 1998-11-25
KR19990044347A (ko) 1999-06-25
ATE323165T1 (de) 2006-04-15
JP4324618B2 (ja) 2009-09-02
NO20070621L (no) 1998-04-27
EP1398379A2 (fr) 2004-03-17
TR200806258T2 (tr) 2008-10-21
CY2612B2 (en) 2010-12-22
AU7158696A (en) 1997-03-27
EP0851927A2 (fr) 1998-07-08
KR100433750B1 (ko) 2004-09-01
EP1347055B1 (fr) 2009-03-18
AU727602B2 (en) 2000-12-14
DE69636046D1 (de) 2006-05-24
NZ319377A (en) 2000-01-28
NO20070618L (no) 1998-04-27
PT851927E (pt) 2004-03-31
MX9801638A (es) 1998-05-31
HU225979B1 (en) 2008-02-28
TR200806259T2 (tr) 2008-10-21
NO324372B1 (no) 2007-10-01
DE69636046T2 (de) 2006-11-23
JP4324597B2 (ja) 2009-09-02
EP1398379A3 (fr) 2004-07-14
JP2006149406A (ja) 2006-06-15
IL123506A (en) 2004-12-15
CZ300688B6 (cs) 2009-07-15
JP2006187292A (ja) 2006-07-20
CZ300953B6 (cs) 2009-09-23
PL186774B1 (pl) 2004-02-27
ATE337399T1 (de) 2006-09-15
BR9612997B1 (pt) 2012-01-10
EP1347055A3 (fr) 2003-11-26
ATE426025T1 (de) 2009-04-15
HUP9900902A3 (en) 2001-03-28
CA2230885C (fr) 2010-02-02
EP1203817B9 (fr) 2006-08-16
BR9610262B1 (pt) 2013-11-26
JP4382160B2 (ja) 2009-12-09
NO980883L (no) 1998-04-27
EP1203817A2 (fr) 2002-05-08
JP2009159982A (ja) 2009-07-23
JP4324596B2 (ja) 2009-09-02
SI0851927T1 (en) 2004-02-29
BR9610262A (pt) 1999-07-06
PT1347055E (pt) 2009-06-19
HU227778B1 (en) 2012-02-28
WO1997009428A2 (fr) 1997-03-13
DE69630457T2 (de) 2004-11-25
EP1712628A3 (fr) 2007-05-23

Similar Documents

Publication Publication Date Title
DK1398379T3 (da) Forbindelser og fremgangsmåder til immunterapi og diagnose af tuberkulose
WO1998016646A3 (fr) Composes et methodes utilises pour l'immunotherapie et le diagnostic de la tuberculose
WO1998053075A3 (fr) Composes pour l'immunotherapie et pour le diagnostic de la tuberculose et leur utilisation
WO1999042076A3 (fr) Composes et methodes pour l'immunotherapie et le diagnostic de la tuberculose
WO2002024739A3 (fr) Antigene du cancer spas-1
CY1108864T1 (el) Ενωσεις για ανοσοθεραπεια και διαγνωση φυματιωσης και μεθοδοι χρησεις τους
AR010517A1 (es) Compuestos y metodos para la inmunoterapia y diagnostico de tuberculosis